Mai O. Kadry | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Assist. Prof. Dr. Mai O.Kadry | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. 📚🧬

Publication Profile

Scopus

Academic and Professional Experience 🌟🎓

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. 📚🔬

 

Educational Background 🎓📘

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. 🌟🔬

 

Training 🧬📚

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. 🔬🧪

 

Research Focus 🧪🧠🧬

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. 🔬✨

 

Publication Top Notes

  • Inflammatory mediators-induced DNA damage in liver and brain injury: Therapeutic approach of 5-Methoy-N-acetyltryptamine – 2024, Toxicology Reports 🧬
  • Necroptosis and autophagy in cisplatinum-triggered nephrotoxicity: Novel insights regarding prognostic and diagnostic potential – 2024, Toxicology Reports 🧪
  • Resveratrol-based nano-formulations as a therapeutic strategy for ovarian carcinoma: Autophagy and SIRT-1 signaling – 2024, Cancer Nanotechnology 💊
  • miR-122-IGF-1R signaling allied with dysregulated lncRNA MALAT-1 in gastric carcinoma – 2024, Toxicology Reports 🔬 (Cited by: 1)
  • Reciprocal crosslink among MeCP2/BDNF/CREB signaling in autism spectrum disorder – 2024, Toxicology Reports 🧠
  • CRISPR-Cas9 genome and lncRNAs for prostate cancer therapy via liposomal compounds – 2024, PLoS ONE 🧬 (Cited by: 1)
  • Collaboration of Hprt/K-RAS/c-Myc mutation in T-lymphocytic leukemia oncogenesis – 2024, Future Science OA 🧪 (Cited by: 1)
  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic stress – 2024, Future Science OA 🧫
  • Titanium dioxide nanostructure-loaded Adriamycin in breast cancer therapy – 2024, Future Science OA 🎗️ (Cited by: 1)
  • Alleviation of doxorubicin adverse effects via drug-delivery systems – 2024, Therapeutic Delivery 🚑

 

Baskaran Nagarethinam | Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Dr. Baskaran Nagarethinam | Molecular Biology | Best Researcher Award

Dr. Baskaran Nagarethinam, National Institute of Food Technology, Entrepreneurship and Management, Thanjavur (NIFTEM-T), India

Dr. N. Baskaran is an Assistant Professor in the Department of Academics and HRD at the National Institute of Food Technology, Entrepreneurship and Management (NIFTEM-T), under the Ministry of Food Processing Industry, Thanjavur, India 🇮🇳. With a Ph.D. in Biochemistry from Annamalai University (2013) and postdoctoral experience at Madurai Kamaraj University, he has a robust academic background 📘. His achievements include the Research Excellence Award (2023), Young Investigator Award (2011), and multiple UGC fellowships 🎖️. Dr. Baskaran’s expertise spans biochemistry and food technology, reflecting his dedication to advancing research and innovation in his field. ✨

 

Publication Profile

Google Scholar

Orcid

Academic Qualifications 📜

Dr. N. Baskaran’s academic journey in biochemistry began with a B.Sc. from Govt. Arts College, Paramakudi, under Madurai Kamaraj University (2005). He further pursued an M.Sc. in Biochemistry at MR College of Arts & Science, Bharathidasan University, earning an impressive 77% in 2008. His academic excellence continued with an M.Phil. from Annamalai University (2009), scoring a 7.73 OGPA, followed by a Ph.D. in Biochemistry from the same university, awarded in 2013. 🧬

Work Experience 💼

Dr. N. Baskaran has a well-rounded academic and research career spanning various reputable institutions. He began as a Guest Lecturer at Government Arts College, Paramakudi (Dec 2012 – Apr 2014), where he gained foundational teaching experience 🧑‍🏫. From July 2014 to June 2016, he served as a UGC Post-Doctoral Fellow at Madurai Kamaraj University, receiving a monthly fellowship of Rs. 38,800, which allowed him to advance his research work 🔬. He then joined SASTRA University, Kumbakonam, as an Assistant Professor (2016–2019), progressing in both position and pay. Currently, he holds an Assistant Professorship at NIFTEM-T, Thanjavur, contributing significantly to food technology and biochemistry research since July 2019 🌾.

 

Professional Recognition & Awards 🏆

Dr. N. Baskaran’s academic and research contributions have earned him multiple accolades over the years. In 2023, he received the prestigious Research Excellence Award at an international conference recognizing multidisciplinary advancements in agricultural and life sciences 🌍. His academic journey was bolstered early on with UGC Junior and Senior Research Fellowships in 2008 and 2010, respectively, and he was honored as a Young Investigator at the 16th WCCN in 2011 🥇. Additionally, he was awarded a UGC Post-Doctoral Fellowship in 2014 and secured second place in his M.Sc. examinations at Bharathidasan University in 2007, underscoring his dedication to excellence 📜.

 

Research Focus

Dr. N. Baskaran’s research primarily focuses on the chemopreventive properties of natural compounds in various cancer models, particularly those induced by 7,12-dimethylbenz[a]anthracene (DMBA) in oral, mammary, and skin carcinogenesis models. His work emphasizes investigating the anti-proliferative, pro-apoptotic, anti-inflammatory, and anti-angiogenic effects of bioactive agents like ferulic acid, carnosic acid, lupeol, and genistein, showing potential as cancer preventive agents. Additionally, his studies explore the genotoxic protection of compounds such as coumarin and chrysin. Dr. Baskaran also examines nutritional profiling and the antioxidant activities of various plant extracts, contributing to fields of oncology, pharmacology, and functional foods. 🌱🧬💊

 

Publication Top Notes

  • Chemopreventive potential of ferulic acid in mammary carcinogenesis in rats
    Cited by: 132 · Published: 2010
  • Carnosic acid: a potent agent against oral carcinogenesis
    Cited by: 104 · Published: 2010
  • Chemopreventive potential of apigenin in oral carcinogenesis
    Cited by: 56 · Published: 2011
  • Proapoptotic, anti-inflammatory potential of carnosic acid in hamster buccal pouch carcinogenesis
    Cited by: 54 · Published: 2013
  • Modulating effect of lupeol in oral carcinogenesis
    Cited by: 36 · Published: 2012
  • Genistein and daidzein protect during mammary carcinogenesis
    Cited by: 34 · Published: 2011
  • Lupeol prevents tumor formation in oral carcinogenesis
    Cited by: 33 · Published: 2012
  • Anti-cell proliferative efficacy of ferulic acid in buccal pouch carcinogenesis
    Cited by: 29 · Published: 2012
  • Anti-tumor potential of andrographolide in hamster buccal pouch carcinogenesis
    Cited by: 25 · Published: 2012
  • Chemopreventive potential of coumarin in buccal pouch carcinogenesis
    Cited by: 23 · Published: 2012

 

 

 

 

 

Junfang Zheng | Molecular Biology Award | Best Researcher Award

Posted on by ScienceFather

Dr. Junfang Zheng | Molecular Biology Award | Best Researcher Award

Dr. Junfang Zheng, Capital medical university, China

Based on Dr. Junfang Zheng’s academic background, current and previous appointments, and honors and awards, he appears to be a strong candidate for the Research for Best Researcher Award. Here’s an evaluation of his qualifications:

Publication profile

Scopus

Education:

Dr. Zheng has a solid educational foundation with a B.M. in Traditional Chinese Medicine from Shanxi University of Chinese Medicine, followed by an M.Sc. in Diagnostics of Traditional Chinese Medicine from Beijing University of Chinese Medicine. His Ph.D. in Pathogenic Biology from Peking University further strengthens his expertise, indicating a robust background in both traditional and modern aspects of medical research.

Current Appointment:

Since 2006, Dr. Zheng has been a Professor in the Department of Biochemistry and Molecular Biology at Capital Medical University. This long-term position reflects his established career and significant contributions to his field.

Previous Appointments:

Dr. Zheng’s previous roles include a Visiting Fellow at the Medical University of Vienna and a Postdoctoral Fellow at Tsinghua University. These positions highlight his international experience and commitment to advancing his research in different academic environments.

Honors, Awards, and Grants:

Dr. Zheng has received multiple prestigious awards, including the Guanghua Fellowship from Peking University, the Eurasia Pacific Uninet Scholarship from Austria, and several funds and honors from Beijing and China. These recognitions underscore his high-impact research contributions and the esteem in which he is held within the academic community.

Publication Top Notes  

  • YTHDF3 phase separation regulates HSPA13-dependent clear cell renal cell carcinoma development and immune evasion 🧬 — Cancer Science, 2024, 0 citations
  • PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway 🧪 — Cell Death and Disease, 2024, 0 citations
  • ARHGAP11A Is a Novel Prognostic and Predictive Biomarker Correlated with Immunosuppressive Microenvironment in Clear Cell Renal Cell Carcinoma 🔬 — International Journal of Molecular Sciences, 2023, 2 citations
  • GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway 🧫 — Frontiers in Oncology, 2022, 6 citations
  • Inhibitor tolerance and bioethanol fermentability of levoglucosan-utilizing Escherichia coli were enhanced by overexpression of stress-responsive gene ycfR 🔬 — Synthetic and Systems Biotechnology, 2021, 4 citations
  • Bioactive peptide apelin rescues acute kidney injury by protecting the function of renal tubular mitochondria 🧬 — Amino Acids, 2021, 11 citations
  • SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis 🧪 — Frontiers in Oncology, 2021, 28 citations
  • iTRAQ-facilitated proteomic analysis of Bacillus cereus via degradation of malachite green 🔬 — Journal of Microbiology, 2021, 2 citations
  • Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation 🧬 — Oncogene, 2020, 26 citations
  • ECHS1 suppresses renal cell carcinoma development through inhibiting mTOR signaling activation 🔬 — Biomedicine and Pharmacotherapy, 2020, 16 citations


Conclusion

Dr. Zheng’s extensive educational background, notable appointments, and numerous awards make him a highly suitable candidate for the Research for Best Researcher Award. His achievements and international experience align well with the criteria for such an award.